pentobarbital and daridorexant both enhance sedation. Modify Therapy/Check Closely. Coadministration increases risk of CNS despair, which may lead to additive impairment of psychomotor efficiency and trigger daytime impairment.pentobarbital will lower the level or effect of venetoclax by influencing hepatic/intestinal enzyme CYP3A4 metabolism.pento